|
gptkbp:instanceOf
|
gptkb:academic
|
|
gptkbp:combines
|
neuroscience
psychopharmacology
|
|
gptkbp:conference
|
gptkb:American_College_of_Neuropsychopharmacology_Annual_Meeting
gptkb:European_College_of_Neuropsychopharmacology_Congress
|
|
gptkbp:emergedIn
|
mid-20th century
|
|
gptkbp:focusesOn
|
addiction
schizophrenia
neurodegenerative diseases
treatment of mental disorders
anxiety disorders
mood disorders
mechanisms of drug action in the brain
|
|
gptkbp:hasApplication
|
personalized medicine
drug development
biomarker discovery
|
|
gptkbp:hasJournal
|
gptkb:Neuropsychopharmacology_(journal)
gptkb:European_Neuropsychopharmacology
gptkb:International_Journal_of_Neuropsychopharmacology
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Neuropsychopharmacology
|
|
gptkbp:professionalOrganization
|
gptkb:American_College_of_Neuropsychopharmacology
gptkb:Asian_College_of_Neuropsychopharmacology
gptkb:International_College_of_Neuropsychopharmacology
gptkb:European_College_of_Neuropsychopharmacology
|
|
gptkbp:relatedTo
|
gptkb:pharmacy
psychiatry
psychology
|
|
gptkbp:studies
|
gptkb:endocannabinoid_system
gptkb:GABA
gptkb:acetylcholine
substance abuse
glutamate
dopamine
norepinephrine
serotonin
antipsychotics
mood stabilizers
antidepressants
anxiolytics
cognitive enhancers
effects of drugs on behavior
effects of drugs on the nervous system
hallucinogens
neurotransmitter systems
opioid system
reward pathways
stimulants
|
|
gptkbp:uses
|
clinical trials
animal models
biochemical assays
neuroimaging techniques
|
|
gptkbp:bfsParent
|
gptkb:Edmond_J._Safra_Chair_in_Neuropsychopharmacology
|
|
gptkbp:bfsLayer
|
6
|